Skip to main content
. 2020 Feb 7;28(1):75–94. doi: 10.3727/096504019X15662966719585

Table 3.

Comparison of CR Between/Among Subgroups Divided by Biochemical Indexes

Parameters N Not CR CR p Value
CBC
 WBC 0.901
  Abnormal (n/%) 80 62 (77.5) 18 (22.5)
  Normal (n/%) 194 149 (76.8) 45 (23.2)
 RBC 0.294
  Abnormal (n/%) 93 75 (80.6) 18 (19.4)
  Normal (n/%) 180 135 (75.0) 45 (25.0)
 ANC 0.268
  Abnormal (n/%) 71 58 (81.7) 13 (18.3)
  Normal (n/%) 202 152 (75.2) 50 (24.8)
 Hb 0.212
  Abnormal (n/%) 105 85 (81.0) 20 (19.0)
  Normal (n/%) 168 125 (74.4) 43 (25.6)
  PLT 0.755
  Abnormal (n/%) 121 92 (76.0) 29 (24.0)
  Normal (n/%) 152 118 (77.6) 34 (22.4)
Liver function
 ALB 0.035
  Abnormal (n/%) 105 88 (83.8) 17 (16.2)
  Normal (n/%) 169 123 (72.8) 46 (27.2)
 TP 0.583
  Abnormal (n/%) 71 53 (74.6) 18 (25.4)
  Normal (n/%) 203 158 (77.8) 45 (22.2)
 TBIL 0.575
  Abnormal (n/%) 79 59 (74.7) 20 (25.3)
  Normal (n/%) 194 151 (77.8) 43 (22.2)
 TBA 0.955
  Abnormal (n/%) 110 84 (76.4) 26 (23.6)
  Normal (n/%) 150 115 (76.7) 35 (23.3)
 ALT 0.843
  Abnormal (n/%) 59 46 (78.0) 13 (22.0)
  Normal (n/%) 215 165 (76.7) 50 (23.3)
 AST 0.036
  Abnormal (n/%) 113 94 (83.2) 19 (16.8)
  Normal (n/%) 159 115 (72.3) 44 (27.7)
 ALP 0.445
  Abnormal (n/%) 101 80 (79.2) 21 (20.8)
  Normal (n/%) 169 127 (75.1) 42 (24.9)
Kidney function
 BCr 0.422
  Abnormal (n/%) 34 28 (82.4) 6 (17.6)
  Normal (n/%) 239 182 (76.2) 57 (23.8)
 BUN 0.047
  Abnormal (n/%) 33 30 (90.9) 3 (9.1)
  Normal (n/%) 237 177 (74.7) 60 (25.3)
Tumor markers
 AFP 0.066
  Abnormal (n/%) 168 135 (80.4) 33 (19.6)
  Normal (n/%) 102 72 (70.6) 30 (29.4)
 CEA 0.482
  Abnormal (n/%) 44 35 (79.5) 9 (20.5)
  Normal (n/%) 204 162 (74.5) 52 (25.5)
 CA199 0.724
  Abnormal (n/%) 65 50 (76.9) 15 (23.1)
  Normal (n/%) 182 136 (74.7) 46 (25.3)

Data are presented as count (%). Comparison between two groups was determined by chi-square test. A value of p < 0.05 was considered significant.